AChE inhibitors can be prescribed with memantine (Figure 5), an uncompetitive and low-affinity N-methyl-D-aspartate (NMDA) receptor (NMDAR) antagonist approved for the treatment of moderately severe to severe AD [119,120,121]. The gene discussed is ACHE; the disease is Alzheimer disease.